Search Results - "Price, Laura A."
-
1
Conformationally Constrained ortho-Anilino Diaryl Ureas: Discovery of 1‑(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y1 Antagonist
Published in Journal of medicinal chemistry (27-11-2013)“…Preclinical antithrombotic efficacy and bleeding models have demonstrated that P2Y1 antagonists are efficacious as antiplatelet agents and may offer a safety…”
Get full text
Journal Article -
2
Biomarker optimization to track the antithrombotic and hemostatic effects of clopidogrel in rats
Published in The Journal of pharmacology and experimental therapeutics (01-07-2007)“…We determined the dose response of the ADP antagonist clopidogrel (0.3-50 mg/kg p.o.) in rat models of thrombosis and provoked bleeding and correlated these…”
Get more information
Journal Article -
3
ORK1, a potassium-selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae. [Erratum: Jan 5, 1999, v. 96 (1), p. 318.]
Published in Proceedings of the National Academy of Sciences - PNAS (12-11-1996)“…A K+ channel gene has been cloned from Drosophila melanogaster by complementation in Saccharomyces cerevisiae cells defective for K+ uptake. Naturally…”
Get full text
Journal Article -
4
Discovery of 4‑Aryl-7-Hydroxyindoline-Based P2Y1 Antagonists as Novel Antiplatelet Agents
Published in Journal of medicinal chemistry (24-07-2014)“…Adenosine diphosphate (ADP)-mediated platelet aggregation is signaled through two distinct G protein-coupled receptors (GPCR) on the platelet surface: P2Y12…”
Get full text
Journal Article -
5
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson’s Disease
Published in ACS medicinal chemistry letters (09-02-2023)“…Parkinson’s disease is the second most prevalent progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia…”
Get full text
Journal Article -
6
New azole antagonists with high affinity for the P2Y(1) receptor
Published in Bioorganic & medicinal chemistry letters (15-06-2013)“…Five-membered-ring heterocyclic urea mimics have been found to be potent and selective antagonists of the P2Y1 receptor. SAR of the various heterocyclic…”
Get full text
Journal Article -
7
New azole antagonists with high affinity for the P2Y1 receptor
Published in Bioorganic & medicinal chemistry letters (15-06-2013)“…Five-membered-ring heterocyclic urea mimics have been found to be potent and selective antagonists of the P2Y1 receptor. SAR of the various heterocyclic…”
Get full text
Journal Article -
8
2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists
Published in Bioorganic & medicinal chemistry letters (01-06-2014)“…Blockade of the P2Y1 receptor is important to the treatment of thrombosis with potentially improved safety margins compared with P2Y12 receptor antagonists…”
Get full text
Journal Article -
9
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent
Published in Bioorganic & medicinal chemistry letters (01-03-2014)“…Spiropiperidine indoline-substituted diaryl ureas had been identified as antagonists of the P2Y1 receptor. Enhancements in potency were realized through the…”
Get full text
Journal Article -
10
Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubility
Published in Bioorganic & medicinal chemistry letters (01-06-2013)“…Preclinical data suggests that P2Y1 antagonists, such as diarylurea compound 1, may provide antithrombotic efficacy similar to P2Y12 antagonists and may have…”
Get full text
Journal Article -
11
Discovery of diarylurea P2Y1 antagonists with improved aqueous solubility
Published in Bioorganic & medicinal chemistry letters (01-06-2013)“…Preclinical data suggests that P2Y1 antagonists, such as diarylurea compound 1, may provide antithrombotic efficacy similar to P2Y12 antagonists and may have…”
Get full text
Journal Article -
12
Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds
Published in Bioorganic & medicinal chemistry letters (15-12-2013)“…A number of new amine scaffolds with good inhibitory activity in the ADP-induced platelet aggregation assay have been found to be potent antagonists of the…”
Get full text
Journal Article -
13
4-Benzothiazole-7-hydroxyindolinyl Diaryl Ureas Are Potent P2Y1 Antagonists with Favorable Pharmacokinetics: Low Clearance and Small Volume of Distribution
Published in ChemMedChem (01-10-2014)“…Current antithrombotic discovery efforts target compounds that are highly efficacious in thrombus reduction with less bleeding liability than the standard of…”
Get full text
Journal Article -
14
Functional coupling of a mammalian somatostatin receptor to the yeast pheromone response pathway
Published in Molecular and Cellular Biology (01-11-1995)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
15
A linear hexapeptide somatostatin antagonist blocks somatostatin activity in vitro and influences growth hormone release in rats
Published in Molecular pharmacology (01-11-1998)“…Somatostatin (SRIF) is the main inhibitory peptide regulating growth hormone (GH) secretion. It has been difficult to establish the role of endogenous SRIF…”
Get more information
Journal Article -
16
Discovery of 2-(Phenoxypyridine)-3-phenylureas as Small Molecule P2Y 1 Antagonists
Published in Journal of medicinal chemistry (28-02-2013)Get full text
Journal Article -
17
2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y sub(1) receptor antagonists
Published in Bioorganic & medicinal chemistry letters (01-06-2014)“…Blockade of the P2Y sub(1) receptor is important to the treatment of thrombosis with potentially improved safety margins compared with P2Y sub(12) receptor…”
Get full text
Journal Article -
18
Discovery of 4-Aryl-7-Hydroxyindoline-Based P2Y 1 Antagonists as Novel Antiplatelet Agents
Published in Journal of medicinal chemistry (24-07-2014)Get full text
Journal Article -
19
Identification of 1-{2-[4-chloro-1′-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4′-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y1 antagonist as an antiplatelet agent
Published in Bioorganic & medicinal chemistry letters (01-03-2014)“…Spiropiperidine indoline-substituted diaryl ureas had been identified as antagonists of the P2Y1 receptor. Enhancements in potency were realized through the…”
Get full text
Journal Article -
20
Conformationally Constrained ortho- Anilino Diaryl Ureas: Discovery of 1-(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y 1 Antagonist
Published in Journal of medicinal chemistry (27-11-2013)Get full text
Journal Article